AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . November 8th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS Therapies - HIV Rebounds after Stopping IL-2, Combination Antiretroviral Drug Therapy
AIDS Therapies - Unusual New NNRTI Has Dual Anti-HIV Activity
Epidemiology (Asia and the Pacific) - AIDS Experts: Asia Must Act Fast
AIDS Therapies - Agents Inhibit HIV Replication by Binding to Chemokine Receptor
At-Risk Populations - Dutch Study Targets Migrants for AIDS Prevention
Drug Resistance - Baseline Drug Resistance Assays May Help Predict Protease Inhibitor Failure
HIV/TB Coinfection - Skin Test Positivity Directly Related to Immune Status in HIV/TB Patients
Pharmacokinetics (Animal Studies) - U.S. NCI Researchers Study AIDS Drug Lodenosine
Prion Diseases - Subclinical Scrapie Infection Not Influenced by B Cells
Transmission - Health Care Professionals Don't Talk Much to Patients about Oral Sex
AIDS Therapies (Animal Studies) - New CCR5 Antagonist: Anti-HIV Activity, Good Pharmacokinetics
AIDS Therapies (Chemokine Receptor Inhibitors) - Anti-HIV Bicyclam Wheels Forward
AIDS Therapies (Salvage Therapy) - Peptide Offers Hope as Salvage AIDS Therapy
Epidemiology (Asia and the Pacific) - Malaysia Leader Urges AIDS Battle
Epidemiology (Asia and the Pacific) - World Bank Challenges Asia To Confront AIDS Threat
Industry News (AIDS Therapies) - Data Presented on Protease Inhibitor
Industry News (AIDS Therapies) - Study Suggest T-20 Levels in Blood Not Affected by Antibody Production
Industry News (Anti-Diarrhea Therapy) - Positive Clinical Results for SB-Normal Stool Formula Announced
Protease Inhibitors - Novel HIV Protease Inhibitor Potent in vitro
Epidemiology (HIV) - United Nations Compiles List of Estimated HIV Prevalence by Region
Evidence-Based Medicine - Expert Says Medical Practice Should Be Confined to Areas with Solid Scientific Basis
HIV Vaccine - CDC Awards $8 Million Contract To Supplement HIV Vaccine Research
Prevention - FHI Awarded HIV Research Contract
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
